Skip to main content

MetLife Value Stock - Dividend - Research Selection

Metlife

ISIN: US59156R1086 , WKN: 934623

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

MetLife, Inc. engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, tort settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, the company offers automobile, homeowners\', and personal excess liability, as well as small business owners\' property, liability, and business interruption insurance products. Further, it provides fixed annuities and pension products; medical and credit insurance products; variable, universal, term, endowment, and whole life insurance products; variable, and fixed and indexed-linked annuities; and protection against costs of long-term health care services. MetLife, Inc. has a strategic alliance with Ernst & Young LLP. The company serves individuals, corporations and their employees, and other institutions through independent agents, property and casualty specialists, sales forces, sales teams and relationship managers, and other organizations, as well as through career agency, bancassurance, direct marketing, brokerage, and other third-party distribution and e-commerce channels. MetLife, Inc. was founded in 1863 and is headquartered in New York, New York.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Berkshire Taps Yen Bonds: Does This Signal Confidence in Japan?

2026-04-17
BRK.B sells 272.3B in yen bonds, hedging currency risk and funding Japan bets as its trading-house stakes jump in value.

Live Nation Court Loss Leaves Breakup of Ticket Seller to Judge

2026-04-15
(Bloomberg) -- Live Nation Entertainment Inc.’s loss in a landmark antitrust trial follows years of regulatory scrutiny of its dominance in the live events business and sets the stage for a possible breakup of the largest US concert promoter and ticket seller.After a six-week trial in Manhattan, which featured testimony from high-profile figures in the music industry and Live Nation Chief Executive Officer Michael Rapino, a federal jury on Wednesday ruled the company illegally monopolized the li

Live Nation Illegally Monopolized Live Events, Jury Says

2026-04-15
(Bloomberg) -- Live Nation Entertainment Inc., the largest US concert promoter and ticket seller, illegally monopolized the live events industry and overcharged fans, a New York federal jury concluded Wednesday.Following a six-week trial, the jury found in favor of a coalition of 33 states and Washington DC who sued the company, handing a massive victory on all their antitrust claims after the US Justice Department bowed out of the case with a settlement after the first week. The jury of seven w

MetLife Supports Climate Innovation Through the Strauch Cleantech to Market Program, Advancing Sustainable Solutions

2026-04-15
NORTHAMPTON, MA / ACCESS Newswire / April 15, 2026 / Congratulations to all The Strauch Cleantech to Market Program (C2M) students who presented at the 2025 Climate Tech Summit at the University of California, Berkeley, Haas School of Business. This ...

SCOA Real Estate Partners Welcomes New Associate Joe Wickenhauser

2026-04-15
SCOA Real Estate Partners (SREP), a subsidiary of Sumitomo Corporation of Americas (SCOA) and leading equity provider for residential and industrial development projects across the US, is pleased to announce the addition of Joe Wickenhauser as an Associate within its Industrial Investment team.

MetLife Recommends Shareholders Reject "Mini-Tender" Offer by Potemkin Limited

2026-04-14
NEW YORK, April 14, 2026--MetLife, Inc. (NYSE: MET) today announced that it has received notice of an unsolicited mini-tender offer by Potemkin Limited ("Potemkin") to purchase up to 100,000 shares of MetLife, Inc. common stock from MetLife shareholders. The offer is for approximately 0.02 percent of MetLife shares of common stock outstanding as of March 31, 2026. Potemkin’s offer price of $44.20 per share is approximately 41.35 percent lower than the $75.36 closing price of MetLife common stock

MetLife Says Received Notice Of An Unsolicited Mini-Tender Offer By Potemkin To Purchase Up To 100,000 Shares Of Co.; MetLife Recommends That Shareholders Do Not Tender Their Shares In Response To Potemkin's Offer

2026-04-14
MetLife, Inc. (NYSE:MET) today announced that it has received notice of an unsolicited mini-tender offer by Potemkin Limited ("Potemkin") to purchase up to 100,000 shares of MetLife, Inc. common stock from MetLife

MetLife Recommends Shareholders Reject “Mini-Tender” Offer by Potemkin Limited

2026-04-14
MetLife, Inc. today announced that it has received notice of an unsolicited mini-tender offer by Potemkin Limited to purchase up to 100,000 shares of MetLife, Inc. common stock from MetLife...

AIG Stock Drops 9% YTD: Should Investors Buy Before the Bounce?

2026-04-14
American International is down 9% YTD, but improving underwriting mix, cost discipline and strong capital deployment may set the stage for a rebound.

B of A Securities Maintains Buy on MetLife, Lowers Price Target to $99

2026-04-14
B of A Securities analyst Joshua Shanker maintains MetLife (NYSE:MET) with a Buy and lowers the price target from $103 to $99.